RE:RBCRBC's TP is $13 u.s., not $23, but still pretty decent...
2:53 PM EDT, 08/04/2021 (MT Newswires) -- RBC Capital has kept its Outperform and US$13 TP on Viemed Healthcare.
"VMD's Q2 2021 exceeded our expectations and the Street's, as new patient setups began to ramp back up, enabling core topline growth to show signs of acceleration and strong margin expansion, returning to historic levels."